Lynch Karen S — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Lynch Karen S has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Profile

Karen S. Lynch is the President and CEO of CVS Health, a role she has held since February 2021. She has extensive experience in the healthcare industry and previously served as the President of Aetna, a subsidiary of CVS Health.

Board memberships

• CVS Health
• Aetna
• Automatic Data Processing Inc
• Thermo Fisher Scientific Inc

Awards & honors

• Led CVS Health's transformation into a healthcare company
• Oversaw the acquisition of Aetna
• Recognized for leadership in healthcare innovation

Recent Transactions

Companies — Last 90 Days

• THERMO FISHER SCIENTIFIC INC. (TMO) — 2 filings, last 2026-06-30

Frequently Asked Questions

Who is Lynch Karen S?

Karen S. Lynch is the President and CEO of CVS Health, a role she has held since February 2021. She has extensive experience in the healthcare industry and previously served as the President of Aetna, a subsidiary of CVS Health.…

How many SEC Form 4 filings has Lynch Karen S submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Lynch Karen S's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week